Patents by Inventor Claudie Verwaerde

Claudie Verwaerde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6683052
    Abstract: The invention concerns any lipopeptide characterized in that it comprises: a peptide part comprising the peptide sequence consisting of about 30 to about 50 of the last contiguous amino acids of the interferon-&ggr; (IFN-&ggr;) C-terminal end of mammals, whereof, if required, the last 3 to 20 amino acids have been suppressed; and one or several lipophilic parts comprising C4-C20 chain of carbon atoms, saturated or unsaturated, linear or branched, or a steroid group. The invention also concerns any lipopeptide such as defined above containing one or several CD8, and/or CD4, and/or B epitopes. The invention further concerns medicines or vaccines containing any polypeptide such as defined above.
    Type: Grant
    Filed: November 20, 2000
    Date of Patent: January 27, 2004
    Assignees: Institut National de la Sante et de la Recherche Medicale Inserm, Institut Pasteur de Lille, Centre National de la Recherche Scientifique
    Inventors: Kader Thiam, Claude Auriault, Helene Gras-Masse, Estelle Loing, Claudie Verwaerde, Jean Gerard Guillet